Cargando…
Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients
Autores principales: | Ieven, Toon, Van Weyenbergh, Thomas, Vandebotermet, Martijn, Devolder, David, Breynaert, Christine, Schrijvers, Rik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492825/ https://www.ncbi.nlm.nih.gov/pubmed/34626857 http://dx.doi.org/10.1016/j.jaip.2021.09.039 |
Ejemplares similares
-
Endotyping of IgE-mediated polyethylene glycol and/or polysorbate 80 allergy.
por: Ieven, Toon, et al.
Publicado: (2023) -
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
por: Ieven, Toon, et al.
Publicado: (2022) -
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
por: Nappi, Emanuele, et al.
Publicado: (2023) -
COVID-19 Vaccination in Patients with Documented Reactions to Polyethylene Glycol or Polysorbate
por: Tang, Monica, et al.
Publicado: (2022) -
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics
por: Otani, Iris M., et al.
Publicado: (2022)